ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $225,949 | -13.2% | 6,419 | 0.0% | 0.00% | – |
| Q4 2022 | $260,355 | +16.8% | 6,419 | -5.0% | 0.00% | – |
| Q3 2022 | $223,000 | -11.5% | 6,758 | -5.5% | 0.00% | – |
| Q2 2022 | $252,000 | -3.8% | 7,152 | +25.8% | 0.00% | – |
| Q1 2022 | $262,000 | -30.1% | 5,687 | +0.7% | 0.00% | -100.0% |
| Q4 2021 | $375,000 | +4.5% | 5,649 | -1.8% | 0.00% | 0.0% |
| Q3 2021 | $359,000 | +28.2% | 5,753 | +70.0% | 0.00% | – |
| Q2 2021 | $280,000 | -0.4% | 3,385 | -77.9% | 0.00% | -100.0% |
| Q1 2019 | $281,000 | – | 15,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |